Streptococcus pneumoniae News and Research

RSS
Streptococcus pneumoniae, or Pneumococcus, is a very common bacterial infection in both industrialized and developing countries. In particular, young children and the elderly represent high-risk populations of developing pneumococcal infections. According to the WHO, the bacterium kills up to one million children under the age of five years each year worldwide. It accounts for many Bacterial Meningitis cases in adults and it is the most common cause of Bacteraemia, Pneumonia, Meningitis and Otitis media in young children.
Scientists find how pneumonia bacteria get sugar boost to survive

Scientists find how pneumonia bacteria get sugar boost to survive

Surprising discovery about natural immunity to pneumococcus

Surprising discovery about natural immunity to pneumococcus

Vaccine prevents deadly pneumonia in African children

Vaccine prevents deadly pneumonia in African children

Child care may affect entire community's risks of infection

Child care may affect entire community's risks of infection

Vaccine against pneumonia and invasive pneumococcal disease shows promise

Vaccine against pneumonia and invasive pneumococcal disease shows promise

Invasive pneumonia and antibiotic resistance decreased after childhood streptococcus pneumoniae vaccine introduced

Invasive pneumonia and antibiotic resistance decreased after childhood streptococcus pneumoniae vaccine introduced

Bacterial spread all down to chance: some strains 'just the luckyones'

Bacterial spread all down to chance: some strains 'just the luckyones'

Shape of a protein on the surface of pneumonia bacteria helps germs invade the human bloodstream

Shape of a protein on the surface of pneumonia bacteria helps germs invade the human bloodstream

Molecular Achilles heel in the organism that causes pneumonia

Molecular Achilles heel in the organism that causes pneumonia

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

Pneumococcal vaccine reduces the incidence of middle ear infection and pneumonia

Pneumococcal vaccine reduces the incidence of middle ear infection and pneumonia

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates